-
Je něco špatně v tomto záznamu ?
Cytotoxic effects of Fisturalin-3 and 11-Deoxyfisturalin-3 on Jurkat and U937 cell lines
MR. Mijares, M. Ochoa, A. Barroeta, GP. Martinez, AI. Suarez, RS. Compagnone, P. Chirinos, R. Avila, JB. De Sanctis
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
23128821
DOI
10.5507/bp.2012.089
Knihovny.cz E-zdroje
- MeSH
- apoptóza účinky léků MeSH
- biologické přípravky farmakologie MeSH
- buněčný cyklus účinky léků MeSH
- hematologické nádory farmakoterapie MeSH
- inhibiční koncentrace 50 MeSH
- Jurkat buňky MeSH
- lidé MeSH
- proliferace buněk účinky léků MeSH
- protinádorová antibiotika farmakologie MeSH
- průtoková cytometrie MeSH
- tyrosin analogy a deriváty farmakologie MeSH
- U937 buňky MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Fisturalines are bromotyrosine compounds isolated from marine sponges. Previous studies have shown antineoplasic, antiviral and antibacterial effects in Vitro; however, the possible effects of these compounds in hematologic malignancies have not been assessed. METHODS: In the present study, the antiproliferative and pro apoptotic effects of Fistularin-3 (F) and 11-Deoxyfistularin-3 (DF) were assessed using the MTT method and annexin V/propidium iodide by flow cytometry using the cell lines: Jurkat E6.1 and U937. In addition, the cell cycle was assessed by flow cytometry. RESULTS: Inhibition of the proliferative response was concentration and time dependent. The IC50 of F was 7.39 and 8.10 µM for Jurkat E6.1 and U937 respectively. At 24 and 48 h, in the U937 cell line, but not in the Jurkat cell line, both compounds induced up to 35% annexin V increase. Necrosis was not observed in any case. Compound F induced, in both cell lines, a decrease in the number of cells in the S phase and increase in the G0/G1 phase. In the Jurkat cell line only, there was an increase in the number of cells in the G2/M phase. Compound DF was not as effective as F. CONCLUSIONS: F is more active than DF in repressing the cell cycle and inducing apoptosis. Both compounds are potentially useful in the development of new drugs to treat hematologic malignancies.
Facultad de Ciencias Universidad Francisco de Miranda Apartado 50109 Caracas 1050 A Venezuela
Facultad de Farmacia Universidad Central de Venezuela Apartado 50109 Caracas 1050 A Venezuela
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14049952
- 003
- CZ-PrNML
- 005
- 20200120153314.0
- 007
- ta
- 008
- 140325s2013 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2012.089 $2 doi
- 035 __
- $a (PubMed)23128821
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Mijares, Michael Rodney $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela; Facultad de Farmacia, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
- 245 10
- $a Cytotoxic effects of Fisturalin-3 and 11-Deoxyfisturalin-3 on Jurkat and U937 cell lines / $c MR. Mijares, M. Ochoa, A. Barroeta, GP. Martinez, AI. Suarez, RS. Compagnone, P. Chirinos, R. Avila, JB. De Sanctis
- 520 9_
- $a BACKGROUND: Fisturalines are bromotyrosine compounds isolated from marine sponges. Previous studies have shown antineoplasic, antiviral and antibacterial effects in Vitro; however, the possible effects of these compounds in hematologic malignancies have not been assessed. METHODS: In the present study, the antiproliferative and pro apoptotic effects of Fistularin-3 (F) and 11-Deoxyfistularin-3 (DF) were assessed using the MTT method and annexin V/propidium iodide by flow cytometry using the cell lines: Jurkat E6.1 and U937. In addition, the cell cycle was assessed by flow cytometry. RESULTS: Inhibition of the proliferative response was concentration and time dependent. The IC50 of F was 7.39 and 8.10 µM for Jurkat E6.1 and U937 respectively. At 24 and 48 h, in the U937 cell line, but not in the Jurkat cell line, both compounds induced up to 35% annexin V increase. Necrosis was not observed in any case. Compound F induced, in both cell lines, a decrease in the number of cells in the S phase and increase in the G0/G1 phase. In the Jurkat cell line only, there was an increase in the number of cells in the G2/M phase. Compound DF was not as effective as F. CONCLUSIONS: F is more active than DF in repressing the cell cycle and inducing apoptosis. Both compounds are potentially useful in the development of new drugs to treat hematologic malignancies.
- 650 _2
- $a protinádorová antibiotika $x farmakologie $7 D000903
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a biologické přípravky $x farmakologie $7 D001688
- 650 _2
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a hematologické nádory $x farmakoterapie $7 D019337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a Jurkat buňky $7 D019169
- 650 _2
- $a tyrosin $x analogy a deriváty $x farmakologie $7 D014443
- 650 _2
- $a U937 buňky $7 D020298
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ochoa, Mariana $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
- 700 1_
- $a Barroeta, Amairelys $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
- 700 1_
- $a Martinez, Gricelis Patricia $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela; Facultad de Farmacia, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
- 700 1_
- $a Suarez, Alirica Isabel $u Facultad de Farmacia, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
- 700 1_
- $a Compagnone, Reinaldo Santi $u Escuela de Quimica, Facultad de Ciencias, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
- 700 1_
- $a Chirinos, Perla $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
- 700 1_
- $a Avila, Ramona $u Facultad de Ciencias,Universidad Francisco de Miranda, Apartado 50109, Caracas 1050-A, Venezuela $7 gn_A_00010358
- 700 1_
- $a De Sanctis, Juan Bautista $u Instituto de Inmunologia, Facultad de Medicina, Universidad Central de Venezuela, Apartado 50109, Caracas 1050-A, Venezuela
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 157, č. 3 (2013), s. 222-226
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20140325 $b ABA008
- 991 __
- $a 20200120153650 $b ABA008
- 999 __
- $a ok $b bmc $g 1017424 $s 848522
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 157 $c 3 $d 222-226 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20140325